Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Addington, J. Search for Related Content PubMed Citation Articles by Addington, J. Nicotine Schizophrenia Spectrum Disorders

Group Treatment for Smoking Cessation Among Persons With Schizophrenia

People with schizophrenia smoke more than the general population and more than other psychiatric diagnostic groups. The rate of smoking in the general population is 30 percent, and reported rates for people with schizophrenia range between 62 percent and 81 percent. The author briefly reviews evidence that nicotine's augmentation of dopamine release may account for the high prevalence of smoking in this group. The affective, cognitive, and social difficulties and the symptoms experienced by many patients with schizophrenia indicate that existing smoking cessation programs may not be appropriate for them. The author describes three programs developed for use with this population and reviews evidence of their effectiveness. Preliminary evidence suggests that transdermal nicotine patches are effective and that patients do not misuse them. The author concludes that stopping smoking is possible for individuals with schizophrenia, especially if the treatment is specifically designed for them.

This article has been cited by other articles:

				N. E. Morden, L. A. Mistler, W. B. Weeks, and S. J. Bartels Health Care for Patients with Serious Mental Illness: Family Medicine's Role J Am Board Fam Med, March 1, 2009; 22(2): 187 - 195. [Abstract] [Full Text] [PDF]

				J O Goldberg and J Van Exan Longitudinal rates of smoking in a schizophrenia sample Tob. Control, August 1, 2008; 17(4): 271 - 275. [Abstract] [Full Text] [PDF]

				T. P. George, D. M. Ziedonis, A. Feingold, W. T. Pepper, C. A. Satterburg, J. Winkel, B. J. Rounsaville, and T. R. Kosten Nicotine Transdermal Patch and Atypical Antipsychotic Medications for Smoking Cessation in Schizophrenia Am J Psychiatry, November 1, 2000; 157(11): 1835 - 1842. [Abstract] [Full Text]

				E. R. Lyon A Review of the Effects of Nicotine on Schizophrenia and Antipsychotic Medications Psychiatr Serv, October 1, 1999; 50(10): 1346 - 1350. [Abstract] [Full Text] [PDF]

Get information about faster international access.

Privacy Policy

Copyright © 1998 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us